151,142 members

Skip to content. | Skip to navigation

News

New findings on post-chemotherapy deaths using world-first cancer data

 

Start sharing

If you've got news you'd like to share, let us know and we'll consider it for our news section.
 

New findings on post-chemotherapy deaths using world-first cancer data

The first major report using world-first systemic anticancer treatment (SACT) data has been published by Lancet Oncology.

The report shows that age, general wellbeing and other factors can affect 30-day mortality following chemotherapy for breast and lung cancer.

The data gives new insights about the real-world chemotherapy treatment of patients in the NHS in England which was previously only available from clinical trials. In 2014 alone, the dataset included over 2 million records for over 160,000 different patients.

The study looked at all women with breast cancer (23,228 patients) and all patients with the most common form of lung cancer (9,634 patients) treated with chemotherapy in England in 2014. It examined how many of these patients died within 30 days of the start of their most recent chemotherapy.